NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









iCamuno Biotherapeutics

iCamuno Biotherapeutics

Private
Melbourne, VictoriaHealthcare & Life Scienceshttps://icamunobio.com/

Last Round

VC Round

Sep 22, 2023

Total Funding Raised

$100.3M

Company Overview

iCamuno Biotherapeutics is a biotechnology company that develops cell therapies using induced pluripotent stem cells (iPSC), gene editing, and cellular differentiation technologies for applications in tumor immunology and regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

cell therapyinduced pluripotent stem cellsiPSCallogeneic cell therapyoff-the-shelf cell therapyiNK cell therapycancer immunotherapyregenerative medicineimmuno-oncologygene editingAI drug discoveryclinical stage biotechTransient Naïve TreatmentTNT reprogrammingovarian cancerParkinson's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iCamuno Biotherapeutics Comparables

Compare iCamuno Biotherapeutics with similar companies based on industry and business-model similarity.

iCamuno Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cartherics
91%
HebeCell
84%
Neukio Biotherapeutics
84%

iCamuno Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 22, 2023
Series A ExtensionMar 29, 2021
Series A ExtensionSep 23, 2019
Series AJul 23, 2018

iCamuno Biotherapeutics Investors

Notable investors and investment history

iCamuno Biotherapeutics investors
InvestorRounds
Legend StarSeries A Extension
招银国际金融有限公司Series A Extension
ARCH Venture PartnersSeries A
Northern Light Venture CapitalVC Round, Series A, Series A Extension
BC CapitalSeries A Extension
Biomatics Capital PartnersSeries A
Sequoia CapitalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Monthly visitors increased 69% MoM.

  • Sep 22, 2023

    $16M round led by Zhejiang Provincial Industrial Fund

iCamuno Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iCamuno Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iCamuno Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourne, Victoria
Employee Range8
Year Founded2018
Last FundingSep 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.